BSX Buys S.I. Therapies

Xconomy Boston — 

Natick, MA-based medical devices firm Boston Scientific (NASDAQ: BSX) paid $5.13 million in cash last November to acquire Israel-based S.I. Therapies, according to a report in the Israel business publication Globes. The Natick firm could pay a total of $24.3 million for S.I., a developer of a re-entry cardiac catheter, if certain milestones are reached. The deal was first announced by Boston Scientific in February, alongside its announcement of the acquisition of Sunnyvale, CA-based ReVascular Therapeutics, which is also developing a device to treat artery blockages.